Related Experiment Video
Updated: Aug 18, 2026
Application of Microwave Ablation in Laparoscopic Partial Splenectomy
Published on: November 15, 2024
Partial splenic embolization in myelodysplastic syndrome associated with immune thrombocytopenia
Hakan Ozdogu1, Can Boga, Levent Oğuzkurt
1Division of Hematology, Department of Internal Medicine, Adana Teaching and Medical Research Center, Baskent University Faculty of Medicine, Adana, Turkey.
Background:
Currently, all treatments for patients with myelodysplastic syndrome (MDS) are still experimental. Supportive care, including treatment of infection and transfusion of blood and blood-related products, remains the most important aspect of therapy in these cases. This article discusses the results of partial splenic embolization in a patient who had MDS with refractory anemia.
Methods:
The patient was placed under observation and was given supportive treatment. In addition to MDS with refractory anemia, there were management difficulties related to severe thrombocytopenia after alloimmunization from multiple blood transfusions. Therefore it is thought that partial splenic embolization might be an alternative treatment for the management thrombocytopenia.
Results:
Although the patient did not live long because of the sepsis and ileus, hematologic response was obtained.
Conclusion:
The observation during the treatment in this case suggests that partial splenic embolization may be a valid new alternative for treating thrombocytopenia due to alloimmunization.
Insights
Partial splenic embolization showed promise in managing severe thrombocytopenia in a myelodysplastic syndrome (MDS) patient. This experimental treatment offers a potential new option for patients with refractory anemia and transfusion complications.
Area of Science:
- Hematology
- Interventional Radiology
Background:
- Myelodysplastic syndrome (MDS) treatments are largely experimental, with supportive care being paramount.
- Refractory anemia in MDS presents significant therapeutic challenges, often necessitating blood product transfusions.
Observation:
- A patient with MDS and refractory anemia experienced severe thrombocytopenia due to alloimmunization from multiple transfusions.
- Partial splenic embolization was considered as a potential intervention to manage this thrombocytopenia.
Findings:
- Despite a short survival due to sepsis and ileus, the patient achieved a hematologic response.
- Partial splenic embolization demonstrated a potential to improve hematologic parameters.
Implications:
- Partial splenic embolization may represent a novel therapeutic alternative for managing thrombocytopenia in MDS patients.
- This approach could be valuable for patients with alloimmunization secondary to blood product transfusions.
